Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.
2.

Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy for patients undergoing PCI: a meta-analysis of randomized trials with adjusted indirect comparisons.

Chen Y, Zhang Y, Tang Y, Huang X, Xie Y.

Curr Med Res Opin. 2014 Jan;30(1):37-49. doi: 10.1185/03007995.2013.850067. Epub 2013 Oct 18. Review.

PMID:
24083626
3.
4.

Cilostazol added to aspirin and clopidogrel reduces revascularization without increases in major adverse events in patients with drug-eluting stents: a meta-analysis of randomized controlled trials.

Sakurai R, Koo BK, Kaneda H, Bonneau HN, Nagai R.

Int J Cardiol. 2013 Sep 1;167(5):2250-8. doi: 10.1016/j.ijcard.2012.06.010. Epub 2012 Jun 22.

PMID:
22727963
5.

Addition of cilostazol to conventional dual antiplatelet therapy reduces the risk of cardiac events and restenosis after drug-eluting stent implantation: a meta-analysis.

Chen Z, Qian J, Chen Y, Ma J, Ge J.

J Clin Pharmacol. 2013 May;53(5):532-9. doi: 10.1002/jcph.64. Epub 2013 Feb 22.

PMID:
23436428
6.
7.

A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation.

Jang JS, Jin HY, Seo JS, Yang TH, Kim DK, Kim DS, Kim DK, Seol SH, Kim DI, Cho KI, Kim BH, Park YH, Je HG, Jeong YH, Kim WJ, Lee JY, Lee SW.

Cardiology. 2012;122(3):133-43. doi: 10.1159/000339238. Epub 2012 Jul 24. Review.

PMID:
22832424
8.

Triple antiplatelet therapy vs. dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: an evidence-based approach to answering a clinical query.

Singh I, Shafiq N, Pandhi P, Reddy S, Pattanaik S, Sharma Y, Malhotra S.

Br J Clin Pharmacol. 2009 Jul;68(1):4-13. doi: 10.1111/j.1365-2125.2009.03402.x.

9.

Cilostazol-based triple antiplatelet therapy compared to dual antiplatelet therapy in patients with coronary stent implantation: a meta-analysis of 5,821 patients.

Geng DF, Liu M, Jin DM, Wu W, Deng J, Wang JF.

Cardiology. 2012;122(3):148-57. doi: 10.1159/000338812. Epub 2012 Jul 24. Review.

PMID:
22832561
10.

Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Chen KY, Rha SW, Li YJ, Poddar KL, Jin Z, Minami Y, Wang L, Kim EJ, Park CG, Seo HS, Oh DJ, Jeong MH, Ahn YK, Hong TJ, Kim YJ, Hur SH, Seong IW, Chae JK, Cho MC, Bae JH, Choi DH, Jang YS, Chae IH, Kim CJ, Yoon JH, Chung WS, Seung KB, Park SJ; Korea Acute Myocardial Infarction Registry Investigators.

Circulation. 2009 Jun 30;119(25):3207-14. doi: 10.1161/CIRCULATIONAHA.108.822791. Epub 2009 Jun 15.

11.

[Short-term outcomes of triple antiplatelet therapy after percutaneous coronary intervention].

Han YL, Su QF, Li Y, Wang SL, Jing QM, Ma YY, Wang ZL, Wang DM, Luan B.

Zhonghua Yi Xue Za Zhi. 2006 Apr 25;86(16):1093-6. Chinese.

PMID:
16796832
12.

Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: A meta-analysis of randomized controlled trials.

Zou Y, Hu C, Ye W, Fan L, Xu L, Zhang A.

Thromb Res. 2015 Nov;136(5):870-7. doi: 10.1016/j.thromres.2015.08.018. Epub 2015 Aug 29.

PMID:
26342401
13.

A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.

Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Kang SJ, Park SJ, Lee JH, Choi SW, Seong IW, Lee NH, Cho YH, Shin WY, Lee SJ, Lee SW, Hyon MS, Bang DW, Choi YJ, Kim HS, Lee BK, Lee K, Park HK, Park CB, Lee SG, Kim MK, Park KH, Park WJ; DECLARE-LONG II Study Investigators.

J Am Coll Cardiol. 2011 Mar 15;57(11):1264-70. doi: 10.1016/j.jacc.2010.10.035.

14.

Use of cilostazol in percutaneous coronary interventions.

Rogers KC, Faircloth JM, Finks SW.

Ann Pharmacother. 2012 Jun;46(6):839-50. doi: 10.1345/aph.1Q765. Epub 2012 Jun 5. Review.

PMID:
22669796
15.

Efficacy and safety of adjunctive cilostazol to dual antiplatelet therapy after stent implantation: an updated meta-analysis of randomized controlled trials.

Ding XL, Xie C, Jiang B, Gao J, Zhang LL, Zhang H, Zhang JJ, Miao LY.

J Cardiovasc Pharmacol Ther. 2013 May;18(3):222-8. doi: 10.1177/1074248412468944. Epub 2012 Dec 21.

PMID:
23263383
16.

Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials.

Bangalore S, Singh A, Toklu B, DiNicolantonio JJ, Croce K, Feit F, Bhatt DL.

Open Heart. 2014 Aug 7;1(1):e000068. doi: 10.1136/openhrt-2014-000068. eCollection 2014.

17.

Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis.

Lee SW, Park SW, Hong MK, Kim YH, Lee BK, Song JM, Han KH, Lee CW, Kang DH, Song JK, Kim JJ, Park SJ.

J Am Coll Cardiol. 2005 Nov 15;46(10):1833-7. Epub 2005 Oct 19.

18.

The effectiveness and safety of triple-antiplatelet treatment based on cilostazol for patients receiving percutaneous coronary intervention: a meta-analysis.

Wang P, Zhou S, Zhou R, Liu G, Tang P, He J, Ma C, He Y, Yang J.

Clin Cardiol. 2012 Oct;35(10):598-604. doi: 10.1002/clc.22001. Epub 2012 May 14. Review.

19.

Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study.

Cassese S, De Luca G, Villari B, Berti S, Bellone P, Alfieri A, Montinaro A, Quaranta G, Marraccini P, Piscione F; MATRIX Study Investigators.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):408-16. doi: 10.1002/ccd.23223. Epub 2011 Nov 9.

PMID:
21735531
20.

Meta-analysis of randomized controlled trials on effect of cilostazol on restenosis rates and outcomes after percutaneous coronary intervention.

Friedland SN, Eisenberg MJ, Shimony A.

Am J Cardiol. 2012 May 15;109(10):1397-404. doi: 10.1016/j.amjcard.2012.01.349. Epub 2012 Feb 28. Review.

PMID:
22381162
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk